Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx® Diabetes Risk Score
- 1 November 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 11 (8) , 775-792
Abstract
Type 2 diabetes is a chronic, debilitating and often deadly disease that has reached epidemic proportions. The onset of diabetes can be delayed or prevented in high-risk individuals by diet and lifestyle changes and medications, and hence a key element for addressing the diabetes epidemic is to identify those most at risk of developing diabetes so that preventative measures can be effectively focused. The PreDx (R) Diabetes Risk Score is a multimarker tool for assessing a patient's risk of developing diabetes within the next 5 years. Requiring a simple blood draw using standard sample collection and handling procedures, the PreDx Diabetes Risk Score is easily implemented in clinical practice and provides an assessment of diabetes risk that is superior to other measures, including fasting plasma glucose, glycated hemoglobin, measures of insulin resistance and other clinical measures. In this article, we provide an overview of the PreDx Diabetes Risk Score.Keywords
This publication has 111 references indexed in Scilit:
- Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 DiabetesEpidemiologic Reviews, 2011
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsNew England Journal of Medicine, 2010
- Protective vascular and myocardial effects of adiponectinNature Clinical Practice Cardiovascular Medicine, 2008
- Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetesDiabetologia, 2008
- Inflammation and insulin resistanceFEBS Letters, 2007
- Hemoglobin A1c Predicts Diabetes but Not Cardiovascular Disease in Nondiabetic WomenThe American Journal of Medicine, 2007
- Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective studyDiabetologia, 2007
- Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysisBMJ, 2007
- Evaluation of Tumour Necrosis Factor Alpha, Interleukin‐2 Soluble Receptor, Nitric Oxide Metabolites, and Lipids as Inflammatory Markers in Type 2 Diabetes MellitusMediators of Inflammation, 2006
- Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy WomenJAMA, 2004